Nafamostat Mesilate as an Anticoagulation Strategy for Heparin-Induced Thrombocytopenia: A Case Report
Journal of Blood Medicine · 2026-01 · Volume 17 · 1-6
DOI: 10.2147/jbm.s564615 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Blood Medicine, 2026-01. Verfasst von Shuqin Mei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Kidney Institute of PLA, Department of Nephrology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Kidney Institute of PLA, Department of Nephrology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.
- Department of Nephrology, 905th Hospital of PLA Navy, Shanghai, 200000, People's Republic of China.
- Department of Nephrology and Endocrinology, Shanghai 411 Hospital, Shanghai University, Shanghai, People's Republic of China.
ORCID-Profile: Shuqin Mei, Cheng Xue, Zhiguo Mao
Zitieren
APA
Mei, S., Xue, C., Liu, L., Cui, L., Lv, J., Ruan, M., Mao, Z., Lu, C., Sun, L., & Dai, B. (2026). Nafamostat Mesilate as an Anticoagulation Strategy for Heparin-Induced Thrombocytopenia: A Case Report. Journal of Blood Medicine, Volume 17, 1-6. https://doi.org/10.2147/jbm.s564615
Vancouver
Mei S, Xue C, Liu L, Cui L, Lv J, Ruan M, et al. Nafamostat Mesilate as an Anticoagulation Strategy for Heparin-Induced Thrombocytopenia: A Case Report. Journal of Blood Medicine. 2026;Volume 17:1-6. doi:10.2147/jbm.s564615
BibTeX
@article{Mei2026,
author = {Mei, Shuqin and Xue, Cheng and Liu, Lingling and Cui, Linlin and Lv, Jiayi and Ruan, Mengna and Mao, Zhiguo and Lu, Chunlai and Sun, Lijun and Dai, Bing},
title = {Nafamostat Mesilate as an Anticoagulation Strategy for Heparin-Induced Thrombocytopenia: A Case Report},
journal = {Journal of Blood Medicine},
year = {2026},
volume = {Volume 17},
pages = {1--6},
doi = {10.2147/jbm.s564615}
}
EUVIMED